SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending after reporting its first-ever quarterly adjusted operating profit and robust Q1 delivery guidance, prompting excitement among bulls who view strong margins and record deliveries as a significant turning point. The community is actively engaged in a debate over sustained profitability and a potential short squeeze, as the stock encounters a critical resistance level amid high trading volume.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is surging as the community celebrates a key FDA official's departure, viewed as clearing a major hurdle for Deramiocel's approval for Duchenne Muscular Dystrophy, with strong Phase 3 data to be highlighted at an upcoming conference fueling expectations for a swift regulatory decision.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as the community eagerly anticipates its upcoming Bankable Feasibility Study, which many expect to reveal a significantly higher valuation for the Tanbreez heavy rare earth project; this comes amid active discussion on the stock's strategic importance in the global 'minerals arms race' driven by escalating geopolitical tensions.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is seeing significant investor attention following a substantial Q4 EPS beat and accelerating revenue from its rare disease drug, MIPLYFFA, sparking community discussions about its unexpected profitability and potential for a valuation re-rating or acquisition.

CitroTech, Inc. is an integrated environmental service company, which engages in the provision of field services, remediation transportation, and EHS compliance services. It also offers on-site technical services, on-site and off-site treatment for hazardous and non-hazardous waste. The company was founded on March 14, 1990 and is headquartered in Cheyenne, WY.

CitroTech Inc.

CitroTech Inc. is trending as it presents its differentiated, non-toxic fire-retardant wood technology at an investment conference, aligning with increasing demand driven by escalating wildfires. The community is actively discussing its low float and commercial traction as key factors for potential significant re-pricing and increased investor attention.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is the subject of intense debate ahead of its earnings report, driven by investor concerns over massive capital expenditures and rising debt for AI cloud infrastructure. While community sentiment is bearish on spending and "AI scam" narratives, many bulls see an undervalued opportunity with exploding cloud demand and a substantial contracted revenue backlog.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending due to intense market debate surrounding the ongoing US-Iran conflict, with community discussions polarized between those anticipating further rallies despite geopolitical tensions and others decrying perceived market manipulation and volatility, exacerbated by conflicting reports and unpredictable option premium movements.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is experiencing a massive surge driven by its strategic partnership with Novo Nordisk to distribute branded GLP-1s and the resolution of their patent lawsuit, alleviating a significant commercial overhang. The community is buzzing with bullish sentiment, anticipating a powerful short squeeze fueled by high short interest and recent analyst upgrades, projecting substantial upward price movement.

Kohl's Corp. engages in the operation of family-oriented department stores. Its business line includes apparel, footwear, and accessories for women, men, and children, home products, beauty products, and accessories. The stores generally carry a consistent merchandise assortment with some differences attributable to regional preferences. The company was founded in 1962 and is headquartered in Menomonee Falls, WI.

Kohl`s Corp.

Kohl's Corp

Kohl's is actively discussed after its Q4 earnings report, which, despite softer comparable sales, delivered an EPS beat and highlighted significant balance sheet improvements, leading the community to debate its strong underlying real estate value and potential for a short squeeze given high short interest.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending amid mixed reactions to a Supreme Court ruling on past tariffs, with the market's volatile response confusing many who anticipated a rally. The community remains deeply divided, with some viewing the depressed share price as a long-term buying opportunity, while others warn of a "value trap" given ongoing challenges in China, inventory, and strategic concerns ahead of its crucial upcoming earnings report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Deutsche Bank upgraded Teladoc to Buy from Hold and set a price target of $11, more than double Monday’s closing price.</li><li>Deutsche Bank noted a “potential exit scenario” for Teledoc Health after Talkspace was acquired by Universal Health.</li><li>UHS’ Talkspace acquisition is “a clear positive for Teladoc,” said BoFA.</li></ul>Teladoc Health (TDOC) drew investor interest on Tuesday, with its shares surging more than 10% in pre-market trading, following a couple of bullish brokerage actions, citing the stock’s “compelling” valuation.If the pre-market levels hold, <a href="https://stocktwits.com/symbol/TDOC">TDOC stock</a> could open at its highest price since Jan. 26, 2026.The company caught brokerages’ attention after its peer <a href="https://stocktwits.com/symbol/TALK">Talkspace (TALK)</a> signed a deal to be acquired by <a href="https://stocktwits.com/symbol/UHS">Universal Health Services (UHS)</a> for $5.25 per share, or about $835 million, on Monday. The transaction is expected to close in the third quarter of 2026.<h2 class="st-heading-2">Analyst Highlights “Potential Exit Scenario” For Teladoc</h2>Deutsche Bank upgraded Teladoc to ‘Buy’ from ‘Hold’ and set a price target of $11, according to&nbsp;The Fly. This represents a 107% upside from the stock’s closing price of $5.3 on Monday.The brokerage said Teladoc’s valuation looks “compelling” at current levels and believes the company has a “deliverable strategy” for BetterHelp, its online therapy platform. Deutsche Bank also noted a “potential exit scenario”, pointing to a comparable transaction that could serve as a roadmap for the company.While BetterHelp has recently faced declining growth, the firm believes Teladoc’s integrated care segment continues to expand, and management has a long-term plan to stabilize and return BetterHelp to growth, the firm added.Meanwhile, BofA raised its price target on Teladoc to $8.25 from $7 and maintained a ‘Buy’ rating. UHS’ Talkspace acquisition is “a clear positive for Teladoc” that provides “further support that the market is undervaluing Teladoc's virtual therapy business as well as the rest of Teladoc,” it said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits shifted to “bullish” from “bearish” over the past 24 hours.<img src="https://news.stocktwits-cdn.com/TDOC_jpg_10651f7b4a.webp" alt="TDOC.jpg">Chatter was largely bullish, with one user saying the company would be worth over $200 billion.<stembedurl>https://stocktwits.com/trplbiem/message/647086931</stembedurl>Another user said, “Teledoc is better equipped than any of their competitors.”<stembedurl>https://stocktwits.com/Idonno/message/647090994</stembedurl>Year-to-date, the stock has declined around 17%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-inkt-stock-surge-in-pre-market-today/cZdoFYVRIeu">Why Did INKT Stock Surge 70% In Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Teladoc logo is seen on a smartphone screen and in the background. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

TDOC Stock Surges 10% Pre-Market, Analyst Cites ‘Compelling’ Valuation After Talkspace Deal

Teladoc Health drew investor interest following a couple of bullish brokerage actions after peer Talkspace signed an acquisition agreement with Universal Health Services a day earlier.

TDOC Stock Surges 10% Pre-Market: Wall Street Sees ‘Compelling’ Valuation, Retail Traders Shift Tone

Equity

Teladoc Health (NYSE:TDOC) Upgraded at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft upgraded Teladoc Health from a "hold" rating to a "buy" rating and set a $11.00 price target on the stock in a report on Tuesday...

Hims and Hers Expands Its Technology Driven Consumer Health Platform

HIMS expands its tech-driven care platform with data-led Labs testing, new menopause and testosterone services and global expansion into Canada.

Teladoc Health (NYSE:TDOC) Price Target Cut to $6.00 by Analysts at Citigroup

Citigroup decreased their target price on Teladoc Health from $9.00 to $6.00 and set a "neutral" rating for the company in a research report on Tuesday...

Oppenheimer Cuts Teladoc Health (NYSE:TDOC) Price Target to $7.00

Oppenheimer dropped their price objective on Teladoc Health from $12.00 to $7.00 and set an "outperform" rating for the company in a research report on Tuesday...

Vanguard Group Inc. Raises Stock Holdings in Teladoc Health, Inc. $TDOC

Vanguard Group Inc. boosted its position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 4.2% in the third quarter, according to the company in its most recent filing with the SEC. The...

Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of "Hold" by Brokerages

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) has earned an average rating of "Hold" from the eighteen ratings firms that are covering the company, Marketbeat.com reports. One equities research...

Teladoc Health Q4 Earnings Call Highlights

Teladoc Health (NYSE:TDOC) reported fourth-quarter and full-year 2025 results that management said were generally in line with expectations, while outlining a 2026 plan centered on product innovation...

Canaccord Genuity Group Has Lowered Expectations for Teladoc Health (NYSE:TDOC) Stock Price

Canaccord Genuity Group lowered their price target on Teladoc Health from $12.00 to $10.00 and set a "buy" rating for the company in a report on Thursday...

Teladoc Health (NYSE:TDOC) Price Target Cut to $5.50 by Analysts at Leerink Partners

Leerink Partners lowered their price objective on shares of Teladoc Health from $8.50 to $5.50 and set a "market perform" rating on the stock in a research report on Thursday...

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Iran / Geopolitical tensions

Fed speakers

Macro data

Earnings

What will be the primary market driver this week?

Stocktwits

Stocktwits Polls

Analysts are significantly raising price targets, with Deutsche Bank and BofA citing compelling valuation and projecting targets up to $11.00, suggesting considerable upside.

After hitting significant lows, investors see current prices as extremely undervalued compared to historical highs and industry peers, anticipating a major reversal.

High short interest, potentially over 20%, is fueling speculation that a sharp price increase could trigger a massive short squeeze, catching bearish traders off guard.

Anticipation surrounds new leadership and strategic plans for the BetterHelp segment, with expectations of stabilization and renewed growth driving future momentum.

Traders are keenly watching key technical levels, including $5.85 resistance, to scalp profits amid volatility and determine if upward momentum can be sustained.

TDOC
Teladoc Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TDOC News

TDOCTeladoc Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TDOC News

TDOC
Teladoc Health Inc